Inovio Pharmaceuticals, Inc. INO
NASDAQ · United States · Health Technology
$1.21-0.01 (-0.82%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.07 | -0.22 | +67.7% | $0 | — | +16.9%$0.77→$0.90 |
| Q1 2026 | 2026-05-13 | -0.31 | -0.33 | +6.1% | — | — | -3.5%$1.41→$1.36 |
| Q4 2025 | 2026-03-12 | -0.28 | -0.34 | +17.6% | — | — | -1.8%$1.69→$1.66 |
| Q3 2025 | 2025-11-10 | -0.87 | -0.48 | -81.3% | — | — | -5.7%$2.12→$2.00 |
| Q2 2025 | 2025-08-12 | -0.61 | -0.62 | +1.6% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.51 | -0.74 | +31.1% | — | — | — |
| Q4 2024 | 2025-03-18 | -0.60 | -0.83 | +27.7% | — | — | — |
| Q3 2024 | 2024-11-14 | -0.89 | -1.13 | +21.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.